A Study of NP001 in Subjects With Amyotrophic Lateral Sclerosis (ALS)
Clinical trial NCT01281631 · COMPLETED
Trial details
- NCT number
- NCT01281631
- Sponsor
- Neuraltus Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-02-01
- Primary completion
- 2012-09-01
- Enrollment
- 136
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.